We are live on ! Find out more
CGIM

Cannon Global Investment Management Portfolio holdings

AUM $51.2M
1-Year Est. Return 49.67%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+49.67%
3 Year Est. Return
+104.84%
5 Year Est. Return
10 Year Est. Return
AUM
$51.2M
AUM Growth
+$11.4M
Cap. Flow
+$12.5M
Cap. Flow %
24.38%
Top 10 Hldgs %
39.01%
Holding
110
New
51
Increased
23
Reduced
7
Closed
28

Sector Composition

1 Healthcare 22.05%
2 Financials 15.57%
3 Technology 12.55%
4 Industrials 12.22%
5 Communication Services 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$466B
$7.5M 14.66%
+13,000
New +$7.9M
NSC icon
2
Norfolk Southern
NSC
$76.4B
$2.01M 3.92%
7,000
+800
+13% +$238K
SUI icon
3
Sun Communities
SUI
$15B
$1.5M 2.93%
+11,900
New +$1.54M
LNG icon
4
Cheniere Energy
LNG
$55B
$1.45M 2.83%
5,100
-400
-7% -$92.4K
QGEN icon
5
Qiagen
QGEN
$8.49B
$1.38M 2.69%
+34,400
New +$1.63M
TERN
6
CALL
DELISTED
Terns Pharmaceuticals
TERN
$1.32M 2.57%
+25,000
New +$1.03M
ZM icon
7
Zoom
ZM
$26.7B
$1.31M 2.56%
16,300
+3,100
+23% +$260K
CEPO
8
Cantor Equity Partners I
CEPO
$271M
$1.24M 2.42%
118,000
+15,500
+15% +$162K
EA icon
9
Electronic Arts
EA
$52.4B
$1.22M 2.39%
6,000
+4,900
+445% +$989K
MDGL icon
10
CALL
Madrigal Pharmaceuticals
MDGL
$12.8B
$1.05M 2.04%
+2,000
New +$956K
FOX icon
11
Fox Class B
FOX
$21.7B
$1.02M 1.99%
19,200
+2,600
+16% +$150K
MRVL icon
12
Marvell Technology
MRVL
$169B
$971K 1.9%
9,800
-6,700
-41% -$563K
CEPT
13
DELISTED
Cantor Equity Partners II
CEPT
$958K 1.87%
88,000
+49,100
+126% +$562K
RTAC
14
Renatus Tactical Acquisition Corp I
RTAC
$329M
$953K 1.86%
92,700
+16,635
+22% +$176K
SSNC icon
15
SS&C Technologies
SSNC
$16.8B
$946K 1.85%
14,000
+5,400
+63% +$415K
CAEP
16
DELISTED
Cantor Equity Partners III
CAEP
$864K 1.69%
83,800
+9,800
+13% +$100K
RVMD icon
17
Revolution Medicines
RVMD
$39.6B
$827K 1.61%
+8,500
New +$858K
GTLS icon
18
Chart Industries
GTLS
$806K 1.57%
3,900
+600
+18% +$124K
ALNY icon
19
Alnylam Pharmaceuticals
ALNY
$35.7B
$794K 1.55%
+2,400
New +$817K
CEPF
20
Cantor Equity Partners IV
CEPF
$597M
$771K 1.51%
75,700
+10,700
+16% +$111K
BPOP icon
21
Popular Inc
BPOP
$11.1B
$765K 1.49%
5,700
+3,100
+119% +$416K
ESTA icon
22
Establishment Labs
ESTA
$2.72B
$738K 1.44%
+13,000
New +$888K
CLBT icon
23
Cellebrite
CLBT
$3.85B
$723K 1.41%
+52,500
New +$791K
FERG icon
24
Ferguson
FERG
$45B
$700K 1.37%
+3,000
New +$730K
ABVX
25
Abivax
ABVX
$11.9B
$668K 1.3%
6,000
+3,818
+175% +$452K

Similar funds

Cannon Global Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Cannon Global Investment Management held 110 positions worth $51.2M, up 29% from $39.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cannon Global Investment Management deployed $12.5M of net new capital in Q1 2026, opening 51 new positions and adding to 23 existing holdings. Its largest new stake was Qiagen: 34,400 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 9.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Unifirst Corp, an estimated $992K trimmed.

  • Cannon Global Investment Management's largest Q1 2026 buy was Qiagen: 34,400 shares worth $1.38M.
  • Cannon Global Investment Management added most to Electronic Arts in Q1 2026, an estimated $989K increase.
  • Cannon Global Investment Management's biggest Q1 2026 reduction was Unifirst Corp, cutting an estimated $992K.
  • Cannon Global Investment Management fully exited Walmart Inc in Q1 2026, selling an estimated $1.92M.
  • Cannon Global Investment Management's ten largest holdings make up 39% of its $51.2M portfolio in Q1 2026.
  • Cannon Global Investment Management opened 51 new positions and closed 28 in Q1 2026.
  • Cannon Global Investment Management's portfolio value rose 29% quarter-over-quarter to $51.2M.

Based on Cannon Global Investment Management's 13F filing for Q1 2026, filed 21 Apr 2026.